ipilimumab,nivolumab
bms
['cm-214']
cm-214 os analysis by fksi-19.. compelling data presented by showing the values of pros in clinical trials! #asco22 
Assistant Professor of Medicine at Loyola University Chicago, Division of Heme-Onc. Aspiring translational scientist and GU-oncologist. #conquercancer